Evidence map›Paper›PMID 26080434›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2015

Reply to Ciccolini et al.: Using mathematical modeling to predict response to antiangiogenic therapy in cancer patients.

Dan G Duda, Rebecca S Heist, Dushyant V Sahani, Triantafyllos Stylianopoulos, Jeffrey A Engelman, Rakesh K Jain

Open access · bronzeAbstract readLetterComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Dan G DudaDepartment of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114;
Rebecca S HeistDepartment of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114;
Dushyant V SahaniDepartment of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114.
Triantafyllos StylianopoulosDepartment of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114;
Jeffrey A EngelmanDepartment of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114;
Rakesh K JainDepartment of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114; jain@steele.mgh.harvard.edu.
Massachusetts General Hospital · USHarvard University · US

Funding

Vascular Normalization: Rolse of Perivascular CellsP01CA080124 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI JAIN, RAKESH K. · 2000 to 2016
$35.0M
Role of SDF1a pathway in prostate cancer relapse and metastasis post-radiotherapyR01CA159258 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI DUDA, DAN GABRIEL · 2011 to 2015
$1.6M
NCI NIH HHS P01 CA080124NCI NIH HHS R01 CA159258
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Angiogenesis InhibitorsAntibodies, Monoclonal, HumanizedAntineoplastic Combined Chemotherapy ProtocolsCarcinoma, Non-Small-Cell LungFemaleHumansLung NeoplasmsMaleNeovascularization, PathologicVascular Endothelial Growth Factor AAngiogenesis InhibitorsAntibodies, Monoclonal, HumanizedVascular Endothelial Growth Factor A

Identifiers

PMID26080434
PMCPMC4500270
OpenAlexW1510460296

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.